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ABSTRACT Recent experiments with amyloid b (Ab) peptide indicate that formation of toxic oligomers may be an important
contribution to the onset of Alzheimer’s disease. The toxicity of Ab oligomers depends on their structure, which is governed by
assembly dynamics. Due to limitations of current experimental techniques, a detailed knowledge of oligomer structure at the
atomic level is missing. We introduce a molecular dynamics approach to study Ab dimer formation. 1), We use discrete
molecular dynamics simulations of a coarse-grained model to identify a variety of dimer conformations; and 2), we employ all-
atom molecular mechanics simulations to estimate thermodynamic stability of all dimer conformations. Our simulations of
a coarse-grained Ab peptide model predicts 10 different planar b-strand dimer conformations. We then estimate the free
energies of all dimer conformations in all-atom molecular mechanics simulations with explicit water. We compare the free
energies of Ab(1–42) and Ab(1–40) dimers. We ﬁnd that 1), dimer conformations have higher free energies compared to their
corresponding monomeric states; and 2), the free-energy difference between the Ab(1–42) and the corresponding Ab(1–40)
dimer conformation is not signiﬁcant. Our results suggest that Ab oligomerization is not accompanied by the formation of
thermodynamically stable planar b-strand dimers.
INTRODUCTION
Alzheimer’s disease (AD) is neuropathologically character-
ized by progressive neuronal loss, extracellular amyloid
plaques, and intracellular neuroﬁbrillary tangles (Yankner,
1996; Selkoe, 1997). Fibrillar amyloid plaques, a result of
amyloid b (Ab) peptide aggregation, have been implicated
in the pathogenesis of AD. Recent experimental studies on
Ab peptide (Lambert et al., 1998; El-Agnaf et al., 2000,
2001; Dahlgren et al., 2002) as well as various animal model
studies (Hsia et al., 1999; Mucke et al., 2000; Dodart et al.,
2002; Westerman et al., 2002; Walsh et al., 2002) suggest
that soluble forms of Ab assemblies cause substantial
neuronal dysfunction even before the appearance of amyloid
plaques. Hence, ﬁnding the conformation of these oligo-
meric forms of Ab may be important for understanding of
neurotoxicity in AD (Kirkitadze et al., 2002; Klein et al.,
2001; Klein, 2002a,b; Bucciantini et al., 2002; Kayed et al.,
2003). At present, the precise nature, conformation, and time
evolution from monomer Ab peptides into intermediates is
still unknown.
The ﬁbrillar structure of Ab peptide aggregates is
relatively well established. Experiments have targeted the
structure of Ab ﬁbrils using electron microscopy (Malinchik
et al., 1998; Tjernberg et al., 1999, 2002), x-ray diffraction
(Malinchik et al., 1998; Serpell et al., 2000), electron
paramagnetic resonance spectroscopy (To¨ro¨k et al., 2002)
and solid-state NMR spectroscopy (Balbach et al., 2002;
Petkova et al., 2002; Antzutkin et al., 2002, 2003; Thompson,
2003). The most common view is that Ab(1–40) and Ab(1–
42) in ﬁbrils form parallel b-sheets with a b-turn between
residues Asp-23 and Lys-28. The most ﬂexible regions of
the peptide in a ﬁbril are the ﬁrst 10 amino acids of the
N-terminus, last few amino acids of the C-terminus (residues
39–42), and the b-turn region between residues 23 and 28
(Petkova et al., 2002; To¨ro¨k et al., 2002).
The aggregation process from a monomer Ab peptide via
soluble oligomeric states to ﬁbrils is a complex dynamic
event that depends critically on the peptide concentration,
pH, and solvent properties. Structural studies have shown
that in vitro, Ab ﬁbril formation is preceded by formation of
intermediates, spherical oligomeric states, and protoﬁbrils
(Walsh et al., 1997, 1999; Hartley et al., 1999; Kirkitadze
et al., 2001; Yong et al., 2002). Structural studies on
oligomeric states are in a less advanced stage compared to
those in ﬁbrils. The nature and structure of different
oligomeric states may depend crucially on the speciﬁc
amino acid sequence of the peptide (Nilsberth et al., 2001).
The Ab plaques in AD brain are predominantly comprised of
two Ab alloforms, Ab(1–40) and Ab(1–42). Despite the
relatively small structural difference between these two
alloforms, they display distinct behavior, with Ab(1–42)
being a predominant component of parenchymal plaques
(Suzuki et al., 1994; Iwatsubo et al., 1994; Gravina et al.,
1995), associated with both early onset AD (Scheuner et al.,
1996; Golde et al., 2000) and increased risk for AD (Weggen
et al., 2001). The cause of the clinical differences between
the two alloforms is still unknown. Recent experiments have
shown that in vitro Ab(1–40) and Ab(1–42) oligomerize
through distinct pathways, with Ab(1–42) forming spherical
paranuclei that further assemble into higher-order oligomers
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Several studies found stable soluble Ab low molecular
weight oligomers (Barrow and Zagorski, 1991; Barrow et al.,
1992; Zagorski and Barrow, 1992; Soreghan et al., 1994;
Shen and Murphy, 1995; Podlisny et al., 1995; Roher et al.,
1996; Kuo et al., 1996; Garzon-Rodriguez et al., 1997; Xia
et al., 1995; Enya et al., 1999; Funato et al., 1999; Huang
et al., 2000). Low molecular weight oligomers were found in
culture media of Chinese hamster ovary cells expressing
endogenous or mutated genes (Podlisny et al., 1995; Xia
et al., 1995). Ab(1–40) and Ab(1–42) oligomers, speciﬁ-
cally dimers, were isolated from human control and AD
brains (Kuo et al., 1996, 1998; Enya et al., 1999; Funato
et al., 1999). Dimers and trimers of Ab were isolated from
neuritic and vascular amyloid deposits and dimers were
shown to be toxic to neurons in the presence of microglia
(Roher et al., 1996). Experiments on synthetic Ab peptides
(Garzon-Rodriguez et al., 1997; Podlisny et al., 1998)
showed that soluble Ab(1–40) exists as a stable dimer at
physiological concentrations that are well below the critical
micelle concentration (Soreghan et al., 1994).
It has been shown that the b-sheet content of Ab depends
strongly upon the solvent in which the peptide is dissolved
(Shen and Murphy, 1995). Various experimental studies
(Barrow and Zagorski, 1991; Barrow et al., 1992; Zagorski
and Barrow, 1992; Shen and Murphy, 1995) indicate that
soluble Ab has substantial b-sheet content. Huang et al.
(2000) reported on two types of soluble oligomers of Ab(1–
40) that were trapped and stabilized for an extended period of
time: the ﬁrst type was a mixture of dimers and tetramers
with irregular secondary structure and the second type
corresponded to larger spherical particles with b-strand
structure. Despite some discrepancies in the experimental
results, the studies mentioned above suggest that dimeriza-
tion may be the initial event in amyloid aggregation and thus
dimers may be fundamental building blocks for further ﬁbril
assembly.
Experimental methods, such as circular dichroism, NMR,
and electronmicroscopy, provide only limited information on
the structure of intermediate oligomeric states. Therefore,
there is a motivation to develop new computational ap-
proaches to determine the exact conformation of oligomers at
the atomic level and track the exact pathway from individual
monomer peptides to oligomers and protoﬁbrils in fast and
efﬁcient ways.With the dramatic increase of computer power
in recent decades, it has become possible to study the behavior
of large biological molecular systems by Monte Carlo and
molecular dynamics (MD) simulations (Dinner et al., 2002;
Fersht and Daggett, 2002; Karplus and McCammon, 2002;
Thirumalai et al., 2002; Plotkin and Onuchic, 2002; Mendes
et al., 2002; Mirny and Shakhnovich, 2001; Bonneau and
Baker, 2001; Dill, 1999; Levitt et al., 1997; Wolynes et al.,
1996; Snow et al., 2002; Vorobjev and Hermans, 2001; Zhou
and Karplus, 1997). However, traditional all-atom MD with
realistic force ﬁelds in a physiological solution currently
remains computationally unfeasible. An aggregation process
as allowed by all-atomMD can only be studied on timescales
of up to 107s using such advanced technologies as
worldwide distributed computing (Snow et al., 2002;
Zagrovic et al., 2002). However, in vivo and in vitro studies
suggest that the initial stages of oligomerization occur on
a timescale of 1 s (Bitan et al., 2003a), whereas further
aggregation into protoﬁbrillar and ﬁbrillar aggregates may
span hours (Kayed et al., 2003).
Here we conduct a two-step study of Ab dimer
conformations and their stability using a computationally
efﬁcient algorithm combined with a coarse-grained peptide
model for Ab. We apply a four-bead model for Ab peptide to
study monomer and dimer conformations of Ab(1–42)
peptide (Ding et al., 2003). We use fast and efﬁcient discrete
molecular dynamics (DMD) simulations (Dokholyan et al.,
1998; Smith and Hall, 2001a). The DMD method allows us
to ﬁnd and study a large variety of dimer conformations
starting from initially separated monomers without second-
ary structures. Our coarse-grained model combined with the
DMD method predicts 10 different planar b-strand dimer
conformations. In the second step, we estimate the free
energy of Ab(1–42) and Ab(1–40) dimeric conformations in
a stability study using all-atom MD simulations with explicit
water and well-established force ﬁelds. This second step
enables us to estimate the free energy of different dimeric
conformations and to compare the free energies of Ab(1–42)
and Ab(1–40) for each of the dimer peptides. Our results
suggest that Ab oligomerization is not accompanied by
formation of thermodynamically stable planar b-strand Ab
dimers, and that such dimers of both Ab(1–42) and Ab(1–
40) are equally unlikely to represent thermodynamically
stable oligomeric forms.
METHODS
Discrete molecular dynamics simulations
In a DMD simulation, pairs of particles interact by means of spherically
symmetric potentials that consist of one or more square wells. Within each
well the potential is constant. Consequently, each pair of particles moves
with constant velocity until they reach a distance at which the potential
changes. At this moment a collision occurs and the two particles change their
velocities instantaneously while conserving the total energy, momentum,
and angular momentum. There are three main types of collisions. The
simplest is when particles collide at their hard-core distance, the sum of the
particle radii. In this case, the particles collide elastically, and their kinetic
energy before and after the collision is conserved. In the second case, the
particles enter a potential well of depth DU. In this case, their total kinetic
energy after the collision increases by DU, their velocities increase, and there
is a change in their trajectories. In the third case, particles exit a potential
well of depth DU. Here, total kinetic energy after the collision decreases by
DU. If the total kinetic energy of the particles is greater than DU, they escape
the well. If their total kinetic energy is smaller than DU, the particles cannot
escape and simply recoil from the outer border of the well inward. At low
temperatures, which correspond to low average particle kinetic energies,
particles whose potentials are attractive thus have a tendency to remain
associated with each other.
DMD, unlike traditional continuous MD, is event-driven and as such it
requires keeping track of particle positions and velocities only at collision
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times, which have to be sorted and updated. It can be shown that the speed
of the most efﬁcient DMD algorithm is proportional to N ln N, where N is
the total number of atoms (Rapaport, 1997). In addition, the speed of the
algorithm decreases linearly with the number of discontinuities in the
potential and particle density. In our DMD simulations the solvent is not
explicitly present, which reduces the number of particles in the system.
Consequently, the DMD method is several orders of magnitude faster than
the traditional continuous MD. The DMD simulation method has been so far
successfully applied to simulate protein folding (Zhou and Karplus, 1997;
Dokholyan et al., 1998; Ding et al., 2002a; Borreguero et al., 2002) and
aggregation (Smith and Hall, 2001a,b; Ding et al., 2002b, 2003). In
simulating protein folding and aggregation, coarse-grained models of
proteins have been introduced. In a coarse-grain model the number of atoms
per amino acid is reduced to one, two, or four, which further speeds up the
DMD simulation. Although traditional continuous all-atom MD can
simulate events on timescales of nanoseconds, the DMD method combined
with a coarse-grained protein model can easily reach timescales of seconds
or more, which is long enough to study oligomer formation of up to 100 Ab
peptides.
A coarse-grained model for Ab peptide
The Ab peptide is derived from its larger amyloid precursor protein by
sequential proteolytic cleavages. In amyloid plaques, the two most common
forms of the Ab peptide are Ab(1–40) and Ab(1–42). The amino acid
sequence of Ab(1–42) is DAEFRHDSGYEVHHQKLVFFAEDVGSNK-
GAIIGLMVGGVVIA. The amino acid sequence of Ab(1–40) is the same as
that of Ab(1–42), but shorter by two amino acids at the C-terminus, Ile and
Ala. In our approach we build the Ab peptide model starting from the
simplest model, which captures the geometric properties of the peptide
backbone and takes into account only intra- and interpeptide hydrogen-bond
interactions, which are not amino acid-speciﬁc. The advantage of this
minimalistic approach is that it will eventually allow us to determine those
intra- and interpeptide interactions that are essential for understanding the
initial steps in Ab aggregation process.
The basic amino acid geometry requires that the backbone atoms are
represented by at least three ‘‘atoms’’ or ‘‘beads.’’ In our DMD simulations
we apply the four-bead model (Takada et al., 1999; Smith and Hall, 2001a,b;
Ding et al., 2003) for Ab peptide. In this model, each amino acid in the
peptide is replaced by at most four ‘‘beads.’’ These beads correspond to the
atoms comprising the amide nitrogen N, the alpha carbon Ca, and prime-
carbon C#. The fourth bead, representing the amino acid side-chain atoms, is
placed at the center of the nominal Cb atom. Due to their lack of side chains,
the six glycines in Ab (positions 9, 25, 29, 33, 37, and 38) are represented by
only three beads. In effect, in our model the Ab peptide is a polyalanine
chain with glycines. Two beads that form a permanent bond can assume any
distance between the minimum and maximum bond length. In addition to
permanent bonds between the beads, the model introduces constraints
between pairs of beads that do not form permanent bonds. These constraints
are implemented to account for the correct peptide backbone geometry. The
hard-core radii, minimum and maximum bond lengths, constraints’ lengths,
and their corresponding standard deviations are either calculated from
distributions of experimental distances between pairs of these groups found
in;7700 folded proteins with known crystal structures (Protein Data Bank),
or chosen following the standard knowledge of the geometry of the peptide
backbone (Creighton, 1993). The values of all these parameters have been
reported previously (Ding et al., 2003).
To account for the hydrogen bonding that normally occurs in proteins
between the carbonyl oxygen of one amino acid and the amide hydrogen of
another amino acid, the coarse-grained model implements a bond between
the nitrogen of the ith amino acid, Ni, and the carbon of the jth amino acid,
C#j, as introduced previously (Ding et al., 2003). The planar geometry of the
hydrogen bond is modeled by introducing auxiliary bonds between the left
and the right neighboring beads of Ni and C#j. The hydrogen bond between
Ni and C#j will form only if all six beads are at energetically favorable
distances. Once the hydrogen bond is formed, it can break due to thermal
ﬂuctuations, which can cause energetically unfavorable distances among the
six beads involved in the hydrogen bond. When amino acids i and j belong to
the same peptide, they can form a hydrogen bond only if at least three amino
acids exist between them (to satisfy the 180 NH-CO bond angle). A more
detailed description of the hydrogen bond implementation has been given
elsewhere (Ding et al., 2003). Our current implementation differs slightly
from before (Ding et al., 2003): one of the auxiliary bonds, namely the
auxiliary bond between Ni and the bead N (the nearest neighbor of C#j), has
a shorter equilibrium distance: instead of 5.10 6 0.31 A˚ used previously
(Ding et al., 2003), it is 4.70 6 0.08 A˚. This slight change in the auxiliary
bond length stabilizes the b-hairpin monomer conformation in our model as
described in the results section.
All-atom molecular dynamics in an
explicit solvent
Next we detail how we use all-atomMD simulations in an explicit solvent to
compute the conformational free energy of Ab(1–40) and Ab(1–42)
monomer and dimer conformations.
Preparation of peptide conformations
For Ab(1–40) monomer peptide structures we use 10 NMR structures with
coordinates (Coles et al., 1998) (ID code name 1BA4 of Protein Database
Bank). For each of these 10 Ab(1–40) monomer structures, we construct
a corresponding Ab(1–42) monomer structure by adding two residues, Ile
and Ala, to the C-terminus of the peptide using the SYBYL (Tripos, St.
Louis, MO) molecular modeling package.
All Ab(1–42) dimer conformations in this study are generated by DMD
simulations using the four-bead model as described above. Dimer
conformations, initially in the four-bead representation, are converted into
all-atom representation by using all-atom template amino acids. These
templates are superposed onto the coarse-grained amino acids such that the
four beads of the coarse-grained model coincide with the N, Ca, C#, and Cb
groups of the all-atom template amino acids. The new template coordinates
with increased number of degrees of freedom are optimized for preserving
backbone distances as well as formation of peptide planes. This optimization
is performed by rotating the template amino acid along two axes, the Ca-N
and the C#-Ca axes, using a Monte Carlo algorithm. After positioning the
backbone atoms, the positions of side-chain atoms are determined by
avoiding steric collisions with the backbone and other neighboring residues.
Positioning of side-chain atoms also follows a Monte Carlo algorithm,
during which side-chain atoms are rotated sequentially along the Ca-Cb axis
and the Cb-Cg axis to ﬁnd the optimal combinations of axis angles that
prevent collisions. The backbone structure of the resulting peptide remains
very close to the initial structure of the peptide: the lengths of bonds and
constraints after the conversion are within the limits given by our coarse-
grained model and the root mean square displacement between the starting
four-bead and the ﬁnal all-atom conformation is ,0.5 A˚ in all cases. The
Ab(1–40) dimer conformations corresponding to each Ab(1–42) dimer are
constructed by disposing of the last two amino acids of each Ab(1–42)
dimer conformation.
Calculation of the conformational free energy in water
We estimate conformational free energies of monomers and dimers in a water
environment using all-atom MD simulations. All MD calculations are
performed using the Sigma MD program (Hermans et al., 1994) with
CEDAR force ﬁelds (Ferro et al., 1980; Hermans et al., 1984). We complete
the all-atom reconstruction from above by adding hydrogen atoms and
solvating the peptide(s) in an SPC water model bath (Berendsen et al., 1981).
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Ab peptides are capped by acetyl and N-methyl groups at the N- and
C-terminals, respectively. We use periodic boundary conditions on a cubic
box whose sides extended 12 A˚ beyond the leading edge of the peptide(s) on
all sides. The MD method consists of two stages, equilibration and produc-
tion (Vorobjev et al., 1998; Vorobjev and Hermans, 1999, 2001; Leach,
2001). Equilibration allows both the peptides and water to relax to a local
energy minimum. The steps of equilibration, 1–7, and the production step, 8,
are as follows:
1. Minimize the energy of the water—peptides are kept immobile.
2. Perform MD simulations on the water using the NVT ensemble at
a temperature T ¼ 200 K for 96 ps (the time step is 1 fs)—peptides are
kept immobile.
3. Minimize the energy of the water a second time—peptides are kept
immobile.
4. Minimize the energy of the peptides—water molecules are kept
immobile.
5. Perform MD simulations of the peptide using the NVT ensemble at
a temperature (T ¼ 100 K)—water molecules are kept immobile.
6. Minimize the energy of the peptides a second time—water molecules
are kept immobile.
7. Minimize the energy of the peptides and water molecules simulta-
neously.
8. Perform the production run, i.e., unconstrained MD simulations on the
peptides and water using the NPT ensemble at T ¼ 300 K and P ¼ 1
atm for 196 ps.
At steps 1, 3, 4, 6, and 7 we use the steepest descent energy minimization
method. During steps 2 and 5, which are parts of equilibration, peptide(s)
and water coordinates have to reach a local energy minimum for the given
force ﬁeld and with respect to each other. The temperatures are kept low so
that there are no conformational changes.
During the production run, step 8, we maintain constant temperature and
pressure by Berendsen coupling (Berendsen et al., 1984) and calculate
electrostatic forces using the particle-mesh Ewald procedure (Darden et al.,
1993). We record a snapshot of the conﬁguration every picosecond. We
calculate the free energy for each conformation by averaging the
instantaneous free energy for each of the 196 snapshots. Each of these
snapshots represents a microconﬁguration. We calculate the free energy for
each conﬁguration by the ES/IS method (Vorobjev and Hermans, 1999),
which uses an explicit solvent simulation with an implicit solvent continuum
model:
GA ¼ ÆUmðxÞæA1 ÆWðxÞæA  TSconf;A; (1)
where Æ. . .æA denotes an average over all recorded microconﬁgurations of the
conformation A, Um is the intraprotein conformational energy, and Sconf,A is
the entropy of conformation A. The intraprotein conformational energy, Um,
is a sum of two terms: one is the short-range energy of packing, Um,pack, and
the other is the electrostatic energy due to coulombic interactions, Um,coul.
The solvation free energy,W(x), is the sum of three terms: the ﬁrst one,Gcav,
is the energy required to form a cavity in the solvent; the second one, Gs,vdw,
is a contribution of the van der Waals interactions between solvent and
protein; and the third one, Gpol, is a contribution of the electrostatic
polarization of the solvent and polar components of the solute. Thus the
above equation becomes
GA ¼ ÆUm;packæA1 ÆUm;coulæA1 ÆGcavæA
1 ÆGs;vdwæA1 ÆGpolæA  TSconf;A: (2)
We determine Um and Gs,vdw from the MD trajectory, calculate Gcav as
proportional to the accessible surface area for a given microconﬁguration,
and evaluate Gpol using an implicit model for the solvent as described
elsewhere (Vorobjev and Hermans, 1999).
RESULTS
Characterization of monomer conformations
The secondary structure of both Ab(1–40) and Ab(1–42)
monomer peptides, as determined by NMR conformational
studies in an apolar environment that mimics the lipid phase
of membranes, is predominantly a-helical. Two a-helical
regions exist at residues 8–25 and 28–38, and these regions
are separated by a ﬂexible hinge. The rest of the peptide
adopts random coil-like conformation (Coles et al., 1998;
Crescenzi et al., 2002).
To characterize the monomer conformations in our coarse-
grained model, we calculate an average potential energy in
dependence on the temperature. The energy unit corresponds
to the potential energy of one hydrogen bond in our model,
so that the absolute average of the potential energy is equal to
the average number of hydrogen bonds in the monomer
conformation, and the temperature unit is equal to the energy
unit. At each temperature 0.080 , T , 0.155, we perform
35 3 106 time step-long simulations. We start each run with
an initial conformation equal to the observed NMR confor-
mation with predominantly a-helical secondary structure
(Crescenzi et al., 2002). The ﬁrst 15 3 106 steps we
allow for equilibration, whereas we calculate the time
average of the potential energy ÆEæ over the last 20 3 106
time steps.
Our monomer peptide experiences a structural transition
from a predominantly a-helix conformation into a b-strand
conformation at Ta,b ¼ 0.107 6 0.002, in agreement with
previous work (Ding et al., 2003). At a higher temperature,
Tb,RC ¼ 0.1286 0.002, the monomer undergoes a transition
from a b-strand into a random-coil conformation with no
particular secondary structure. Between Ta,b and Tb,RC our
simulations show various types of b-strand rich conforma-
tions.
At temperatures T , 0.107, we observe an a-helix
conformation, which is consistent with the observed solution
monomer conformation in an apolar microenvironment
(Crescenzi et al., 2002). This conformation (Fig. 1 a) has
a random coil-like tail ;10 amino acids long at the
N-terminus and another random coil-like tail ;2–4 amino
acids long at the C-terminus. At residues 11–40 there are two
a-helices, separated by a hinge at residues 25–28. The aver-
age potential energy of this conformation is ÆEæ ¼ 28 6 2.
At temperatures 0.107 , T , 0.117, we observe various
b-strand conformations, mostly with two or three b-turns,
corresponding to three or four b-strands (Fig. 1, b and c).
The average potential energy of these conformations is ÆEæ¼
17 6 1. The b-hairpin conformation, i.e., a 2-b-strand
conformation with one b-turn, shown in Fig. 1 d, is found as
a predominant conformation at temperatures T, 0.117, T,
0.126. This conformation is characterized by a random-coil
tail at residues 1–9 and by a well-deﬁned and localized
b-turn which is positioned at residues 23–28. The average
potential energy of this conformation is ÆEæ ¼ 13 6 1.
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The observed b-turn between residues Asp-23 and Lys-28
is in agreement with recent NMR studies of Ab ﬁbrillar
structure (Petkova et al., 2002). In the following, we provide
an empirical explanation for the occurrence of this well-
deﬁned b-turn in our model. We hypothesize that within our
model the occurrence of a b-turn at residues 23–28 is induced
by the particular location of the six glycines in the Ab(1–42)
peptide. To test this hypothesis, we replace all glycines within
the Ab(1–42) peptide with alanines and perform simulations
as described above. Our results (Fig. 2) show the probability
for the amino acid at a certain position to be part of a b-turn
both for the original Ab peptidemodel (with glycines) and the
one without glycines (42 amino acid-long polyalanine chain).
The results show that 1), the presence of glycines on average
shifts the center of the b-turn from residues 20–22 for the
chain with no glycines to 25–27 for the chain with six
glycines, and 2), the probability distribution in the presence of
glycines is strongly peaked at residues 25–27, which makes
these three residues part of the b-turn with.95% probability,
and thus the b-turn is well-deﬁned.
The residues 25–27 of the Ab peptide correspond to
glycine, serine, and asparagine, the residues that have,
according to the classical phenomenological approach of
Chou and Fasman (1974), the highest probability to be
within a b-turn. In our coarse-grained model the occurrence
of the b-turn at 23–28 can be understood as a consequence of
two tendencies: 1), a tendency to maximize the number of
hydrogen bonds, which prefers a b-turn at the middle of the
peptide chain, centered at resides 20–22; and 2), a tendency
of six glycines to be associated with more ﬂexibility, thus
a b-turn. Consequently, the center of the b-turn is shifted
from residues 20–22 to residues 25–27 and is well-deﬁned.
Planar b-strand dimer conformations
of Ab(1–42)
We investigate next dimer formation of Ab(1–42) peptides.
The initial monomer conformations are taken from the Protein
Data Bank and correspond to the observed NMR structures of
Ab(1–42) monomers in an apolar environment (Crescenzi
et al., 2002). To obtain different starting random-coil
conformations, we place two monomers with mostly
a-helical secondary structure in a cubic box with a side
length of 100 A˚. The centers of masses of the two monomers
are initially;50 A˚ apart and their orientations parallel. Next,
we heat the system up to a temperature T¼ 0.50, which is far
above the observed Tb,RC temperature. The a-helical
secondary structure of individual monomer peptides is
dissolved in ;200 simulation steps, producing two peptides
with different random-coil conformations. We use many
similarly generated pairs of peptides with random-coil
conformations as initial conﬁgurations in our study of dimer
formation. Dimer formation simulations are done at a constant
FIGURE 1 Conformations of an Ab(1–42) monomer peptide model as
a function of temperature: (a) mostly a-helix conformation at T¼ 0.100 with
two a-helices at residues 12–23 and 29–38, and a hinge at residues 23–28;
(b) 3-b-strand conformation at T ¼ 0.108; (c) 4-b-strand conformation at
T ¼ 0.115; and (d) b-hairpin conformation at T ¼ 0.120 characterized by a
b-turn at residues 23–28.
FIGURE 2 Two distributions that give the probability for an amino acid at
a residue number (position in the chain) to be within a b-turn. These
simulations are done at temperature T ¼ 0.125, where our model for Ab(1–
42) yields a stable b-hairpin conformation. The curve with solid circles
corresponds to the altered chain (no glycines) and the curve with solid
triangles corresponds to the original Ab(1–42) model with six glycines. The
distributions are calculated on the basis of 28 (the model with no glycines)
and 38 (the Ab(1–42) model) different b-hairpin conﬁgurations. For each
b-hairpin conformation we use a visual molecular dynamics (VMD)
(Humphrey et al., 1996) visualization package to determine and count all the
residues with a b-turn (determined visually and conﬁrmed by the secondary-
structure analysis within VMD). The probability to be in the b-turn is
determined as a ratio between the number of conformations in which the
amino acid is part of a b-turn and the total number of conformations.
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temperature and volume.Weperform20 simulations at a ﬁxed
temperature. Each run is 203 106 time steps long. In this way
we explore temperatures T ¼ 0.120, 0.125, and 0.130.
From the above simulations we ﬁnd six possible dimer
conformations with the following characteristics: 1), each
peptide in a dimer is in a b-hairpin conformation with two
b-strands; and 2), all four b-strands (two per peptide) are
planar. We name those dimers according to the inner two
strands of the dimer (each strand is closer to either the
N-terminus or the C terminus and the two inner strands are
either parallel or antiparallel): NN-parallel, NC-parallel, CC-
parallel, NN-antiparallel, NC-antiparallel, and CC-antiparal-
lel. These conformations are schematically presented in Fig.
3, a–f. We ﬁnd four additional dimer conformations with
characteristic 2 described above. Only the inner peptide has
also characteristic 1, whereas the outer peptide is bent around
the inner one, forming a ‘‘nest.’’ We term them nested-
parallel, nested-antiparallel, anti-nested parallel, and anti-
nested antiparallel (in anti-nested conformations the termini
of the two peptides are in the opposite directions). They are
shown in Fig. 3, g–j.
At T ¼ 0.12, we ﬁnd NC-parallel and NC-antiparallel
conformations in 3 out of 20 simulations. The conformations
NN-parallel, CC-parallel, CC-antiparallel, nested antiparal-
lel, anti-nested parallel, and anti-nested antiparallel each
occur in 2 out of 20 simulations. The conformations NN-
antiparallel and nested parallel are each found in 1 out of 20
simulations. At T ¼ 0.13, the most common dimer peptide
conformation is NC-parallel (occurring in 8 out of 20 simu-
lations) and the next most common conformation is NN-
parallel (occurring in 5 out of 20 simulations). We ﬁnd the
NC-antiparallel conformation in 3 out of 20 simulations.
There are four more conformations found, each in 1 out of 20
simulations: NN-antiparallel, CC-parallel, CC-antiparallel
and a nested-antiparallel conformation.
Our dimer simulations at temperatures T $ 0.14 show no
dimerization within the ﬁrst 203 106 simulation steps, even
though typically one of the two peptides adopts one of the
b-strand conformations. We thus conclude that at temper-
atures T. 0.14 there is no dimerization. At temperature T ¼
0.11, we observe a large number of different planar and non-
planar b-strand dimer conformations, which are a mixture of
FIGURE 3 Schematic conformations
of an Ab(1–42) dimer peptide model.
All the conformations are based on a
b-hairpin conformation with a b-turn
at residues 23–28. In our model the
energies of all these conformations are
approximately the same; however, the
probability of the occurrence varies.
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2-, 3-, and 4-b-strand conformations. At temperatures 0.08,
T, 0.11, the dimer conformations are an amorphous mixture
of b-strand and a-helical secondary structure. All these are
omitted from the present all-atom free-energy calculation
study.
Free-energy calculations: Ab(1–40) versus
Ab(1–42) monomer conformations
We ﬁrst calculate the conformational free energies of
monomer peptides of Ab(1–40) and Ab(1–42). We choose
10 different NMR Ab(1–40) monomer structures (Coles
et al., 1998). The secondary monomer structure is mostly
a-helical, similar to Fig. 1 a. These monomer structures were
determined under the same experimental conditions, so their
conformational free energies should be similar. To each of
these structures we add two amino acids, Ile and Ala, to ﬁnd
the corresponding Ab(1–42) monomer conformation. The
estimated free energies are presented in Table 1. Our results
show that all the monomer conformations of Ab(1–40) and
Ab(1–42) have on average the same conformational free
energy, 1034.686 17.75 kcal/mol and 1029.476 10.80
kcal/mol, respectively. Each of the two error bars, 17.75
kcal/mol and 10.80 kcal/mol, is a result of averaging over 10
monomer conformations with free energies, given in Table 1.
These results show that addition of two amino acids to the
C-terminus does not alter the conformational free energy of
the Ab monomer peptide in a water environment at
physiological conditions.
Stability analysis of Ab(1–40) and Ab(1–42)
dimer conformations
The planar b-strand dimer conformations predicted by our
coarse-grained model (Fig. 3) are tested for stability in our
all-atom MD simulations in an explicit water environment at
atmospheric pressure and room temperature. From 10
different Ab(1–42) dimer conformations, we create the
corresponding Ab(1–40) dimers by deleting the last two
amino acids at the C-terminus. For each mechanically stable
dimer conﬁguration, we next calculate the free energy as
described in the Methods section. The ﬁnal free energies of
all mechanically stable dimers are presented in Table 2. One
dimer conformation, e.g., nested antiparallel of Ab(1–40), is
determined to be mechanically only marginally stable and
does not allow for the free-energy calculation.
Tables 3 and 4 give details of the free-energy calculation for
Ab(1–40) and Ab(1–42) dimers: individual terms of the free
energy with the corresponding error bars. During 200
picosecond-long production runs, we sample each individual
contribution to the free energy every picosecond. Thus, we
obtain histograms of all the contributions to the free energies,
each consisting of 200 data points. We estimate the error bars
of each individual term and the total free energy as standard
deviations (widths of the corresponding histograms). The
entropy term is not included in Tables 3 and 4 as it varies
negligibly from trajectory to trajectory. Note that standard
deviations of individual contributions to the free energy
(Tables 3 and 4) are larger than error bars of the total
conformational free energy (Table 2), because these in-
dividual contributions are anticorrelated. With an exception
of oneAb(1–40) dimer, for all the rest of dimer conformations
the free-energy terms (Tables 3 and 4) are all well-behaved,
indicating that these conformations are realistic, i.e., mechan-
ically stable in water. Considering the solvation free energy,
which is determined as a sum of three free-energy
contributions, ÆGcavæA, ÆGs,vdwæA, and ÆGpolæA (columns 3, 4,
5, and 6 of Tables 3 and 4), is negative for all mechanically
stable dimers, suggesting that all these dimer structures are
soluble in water. An evidence that our coarse-grained model
dimers are not unrealistic is presented in Fig. 4 which shows
the root mean square displacement (RMSD) during the
production run for two representative Ab(1–40) dimers, NN-
anti, and CC-anti. RMSDs increase at the beginning of the
production run, but stabilize typically after 100 ps at 2–4 A˚.
Columns 3 and 6 of Table 2 represent the free-energy
differences, DGAb-40 and DGAb-42, between a dimer confor-
mation and two monomer conformations. For the confor-
mational free energy of the Ab(140) and Ab(1–42)
monomer, we take the averages 1034.68 6 17.75 kcal/
mol and 1029.47 6 10.80 kcal/mol (see the previous
subsection). For two Ab(1–40) dimers (NN-anti and CC-
anti), the difference in the free energy (DG) between dimer
and monomers (10.52 and 27.91 kcal/mol) is signiﬁcantly
smaller than the quadrature uncertainty in free-energy
estimates (46.94 kcal/mol). This suggests that these
structures may be marginally thermodynamically stable.
However, because for 19 out of 20 dimer conformations DG
is positive (see Table 2), we conclude that in a water
environment, planar b-strand dimer conformations are
energetically unfavorable compared to a-helical monomer
TABLE 1 Free energies of monomer conformations:
comparison of calculated free energies, GAb–40 and GAb–42, and
the corresponding standard deviations, sG, of Ab monomer
conformations as determined by the NMR experiment
Monomer GAb–40 sG GAb–42 sG
1BA4-01 1036.58 24.39 1026.23 24.99
1BA4-02 1050.25 22.60 1034.13 22.92
1BA4-03 1045.88 23.32 1028.07 21.58
1BA4-04 1045.93 22.72 1032.92 30.42
1BA4-05 1030.62 23.01 1008.66 25.46
1BA4-06 997.14 23.11 1017.85 26.97
1BA4-07 1043.71 24.26 1039.30 22.91
1BA4-08 1016.94 22.70 1027.37 24.15
1BA4-09 1038.70 23.16 1032.68 22.03
1BA4-10 1052.29 25.82 1044.28 19.82
The NMR experiment data are based on work of Coles et al. (1998). The
names of different monomer structures follow the ID code name 1BA4 of
Brookhaven Protein Data Bank (http://www.rcsb.org/pdb/). The free-
energy unit is kcal/mol.
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peptide conformations, and thus thermodynamically most
likely unstable. Comparing conformational free energies of
Ab(1–40) and Ab(1–42) dimers, we ﬁnd that the average
conformational free energies are 2000.81 6 46.94 kcal/
mol and 1967.63 6 52.85 kcal/mol, respectively. Al-
though Ab(1–40) dimers have on average lower conforma-
tional free energy than Ab(1–42) dimers, the difference is
not statistically signiﬁcant.
DISCUSSION AND CONCLUSIONS
In this work, we introduce a molecular dynamics approach
that combines DMD simulations of a coarse-grained Ab
peptide model with all-atom molecular mechanics study of
thermodynamic stability of predicted dimer conformations.
In our simple coarse-grained peptide model, Ab peptide is
a polyalanine chain with glycines. The model only considers
intra- and interpeptide hydrogen bond interactions. Because
the model neglects the amino acid-speciﬁc interactions, it is
in the present form not adapted for modeling the membrane
environment, where reduced dimensionality and hydropho-
bic interactions are critical. In fact, a theoretical model of ion
channel structure of Ab (Durell et al., 1994) is very different
from the dimer structures predicted by our coarse-grained
model. Our model is thus most pertinent to oligomer
formation in solution.
Different dimer conformations, predicted by our coarse-
grained model, are transformed into all-atom representations
by restoring the speciﬁc side chains of Ab peptides. To study
stability of dimer conformations, we apply the all-atom ES/
IS method with realistic force ﬁelds (Vorobjev and Hermans,
1999) to estimate the free energy of predicted dimer
conformations. Within the ES/IS method, a particular source
of error in the conformational free-energy calculation arises
from applying the implicit solvation method to determine the
solvation free energy, which is typically overestimated.
Despite limitations, the ES/IS method has been successfully
applied to the folding problem: the free energy of misfolded
proteins was shown to be higher than the free energy of
naturally folded proteins (Vorobjev and Hermans, 2001).
Our results provide the following insights into the nature
of Ab folding and dimer formation. 1), Our model predicts
a thermally induced conformational change between a pre-
dominantly a-helix to a predominantly b-strand monomer
peptide. This prediction of our model, a change from an
a-helix-rich to a b-strand-rich monomer conformation, is
indirectly supported by recent experiments (Gursky and
Aleshkov, 2000) on temperature dependence of the Ab
conformation in aqueous solutions, which suggest that
thermally induced conformational change to b-strand
transition is not coupled to aggregation and can occur at
the level of monomers or dimers. 2) A monomer peptide in
TABLE 2 Free energies of dimer conformations: comparison of calculated free energies GAb–40 and GAb–42, the corresponding
standard deviations sG, and the free-energy differences DGAb–40 and DGAb–42 of Ab(1–42) and Ab(1–40) dimer conformations
Dimer GAb–40 sG DGAb–40 GAb–42 sG DGAb–42
NN-para 1983.51 29.32 88.10 1994.72 35.03 63.58
NN-anti 2061.09 34.70 10.52 2019.14 38.16 39.15
NC-para 1935.59 32.43 136.02 1937.60 28.65 120.70
NC-anti 1999.38 30.77 72.23 1982.94 40.80 75.36
CC-para 2000.17 30.36 71.44 1871.82 30.13 186.48
CC-anti 2043.70 34.24 27.91 2022.44 35.77 35.86
nest-para 1964.90 40.24 106.71 1989.43 35.05 68.87
nest-anti N/A N/A N/A 1950.07 45.45 108.23
anti-nest-para 2028.34 42.19 34.27 2022.27 30.97 36.03
anti-nest-anti 1988.27 35.97 83.34 1972.38 33.80 85.92
The free-energy unit is kcal/mol.
TABLE 3 Individual free-energy terms contributing to the free energy of Ab-(1–40) dimer conformations (hGs, vdwiA 5
hGs, vdw, 6iA 1 hGs, vdw, 12iA)
Dimers ÆUm, packæ ÆUm, coulæ ÆGcavæA ÆGs, vdw, 6æA ÆGs, vdw, 12æA ÆGpolæA
NN-para 404.80 (620.43) 724.58 (658.18) 423.46 (68.31) 1366.17 (632.31) 1193.20 (638.79) 1914.21 (651.82)
NN-anti 363.71 (621.97) 899.38 (667.06) 404.58 (69.89) 1219.29 (629.92) 1015.56 (635.49) 1656.75 (667.19)
NC-para 461.02 (622.27) 510.35 (675.35) 482.24 (610.23) 1376.47 (679.80) 1226.57 (69.20) 2029.15 (686.25)
NC-anti 430.91 (619.96) 304.87 (631.85) 435.23 (66.04) 1333.24 (628.48) 1122.47 (638.34) 2274.48 (628.89)
CC-para 431.13 (619.43) 328.83 (653.26) 432.05 (65.09) 1332.58 (628.75) 1120.62 (638.98) 2249.10 (649.46)
CC-anti 405.29 (619.06) 455.88 (680.18) 438.76 (65.77) 1326.89 (628.07) 1102.41 (636.69) 2134.19 (670.23)
nest-para 365.21 (618.72) 802.26 (645.35) 398.71 (66.37) 1298.78 (629.30) 1148.09 (634.89) 1799.23 (635.00)
nest-anti N/A N/A N/A N/A N/A N/A
anti-nest-para 375.69 (622.01) 409.77 (696.34) 417.78 (65.15) 1311.05 (629.57) 1116.50 (642.58) 2185.20 (684.52)
anti-nest-anti 351.90 (624.82) 931.58 (654.50) 383.77 (69.38) 1202.00 (634.97) 1028.69 (635.68) 1582.09 (657.41)
Individual free-energy terms are as deﬁned in Eq. 2. The free-energy unit is kcal/mol. Individual error bars are given in parentheses.
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our coarse-grained model adopts a b-hairpin conformation
with a b-turn between Asp-23 and Lys-28. The presence of
this b-turn is consistent with a structural model for Ab ﬁbrils
based on solid-state NMR experimental constraints (Petkova
et al., 2002). In our model, the b-hairpin monomer
conformation is stabilized by intrastrand hydrogen bonds,
whereas in the structural model for Ab ﬁbrils (Petkova et al.,
2002) the peptides in a ﬁbril interact by interpeptide
hydrogen bonds along the ﬁbrillar axis. An intrastrand salt
bridge interaction between Asp-23 and Lys-28 may play
a critical role in stability of ﬁbrils (Ma and Nussinov, 2002).
In our model, the b-turn is not formed due to any amino acid-
speciﬁc interactions. Expanding our coarse-grained model to
include salt bridge and hydrophobic interactions, which are
amino acid-speciﬁc, will allow us to model a wider range of
oligomeric structures, including the bent double-layered
hairpin-like structure observed in experiments (Petkova et al.,
2002) and all-atom simulations (Ma and Nussinov, 2002). 3),
We show by using all-atom simulations that planar, b-sheet-
like dimer conformations, predicted by our model, are in
general energetically unfavorable compared to the a-helical
monomer conformations in water environment. Moreover,
the free-energy comparison of Ab(1–40) and Ab(1–42)
dimer conformations shows that there is no signiﬁcant free-
energy difference between these two alloforms. 4), Ab dimer
conformations, predicted by the coarse-grained model, do
not change drastically during our all-atom simulations, and
they yield reasonable conformational free energies, which
suggests that our simple coarse-grained model represents
a good theoretical base upon which we will be able to
develop a more sophisticated model by incorporating amino
acid-speciﬁc interactions.
In conclusion, planar b-strand Ab dimers as predicted by
our coarse-grained model cannot account for experimentally
observed differences in Ab oligomer formation between
Ab(1–40) and Ab(1–42) alloforms (Bitan et al., 2003a). It is
not understood yet at which stage of oligomer formation
those differences occur and what is the exact mechanism that
drives the two alloforms along different pathways. To ac-
count for oligomer formation differences between the two
Ab alloforms, our coarse-grained model can be expanded to
include other intra- and interpeptide interactions between
amino acids, in particular the ones that originate in charge
and in hydropathic character of the side chains, the im-
portance of which has been demonstrated recently in vitro
(Bitan et al., 2003b,c).
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